THIS! ➡️ "Ovaries lose function earlier than the rest of the body, leading to many women spending two thirds of their lives dealing with a degree of infertility, and one third of their lives in a stage of poor health post-menopause. Currently with our lead program, Fertilo, we are looking to reduce the hormonal burden on women and address infertility. Now with this award, we have sufficient resources to further apply our cell engineering technology and bring forward a program for women going through menopause, an area with even fewer treatment options.” - Dina Radenkovic (Turner) Congrats Gameto, Dina Radenkovic (Turner) and team on this well-earned $10M grant award.
We’re excited to share that we have been selected by the Advanced Research Projects Agency for Health (ARPA-H) as an awardee of the #SprintForWomensHealth! 🎉 We will receive $10 million in funding through the initiative’s launchpad track for later-stage development health solutions. "We are excited to be an ARPA-H Sprint for Women’s Health awardee, and advance the Ameno program through preclinical studies and hopefully into human trials," said Dina Radenkovic (Turner), Co-founder and CEO of Gameto. "Ovaries lose function earlier than the rest of the body, leading to many women spending two thirds of their lives dealing with a degree of infertility, and one third of their lives in a stage of poor health post-menopause. Currently with our lead program, Fertilo, we are looking to reduce the hormonal burden on women and address infertility. Now with this award, we have sufficient resources to further apply our cell engineering technology and bring forward a program for women going through menopause, an area with even fewer treatment options.” The ARPA-H #SprintForWomensHealth is addressing critical unmet challenges in women’s health, championing transformative innovations, and tackling health conditions that uniquely or disproportionately affect women. Read our announcement. → https://lnkd.in/dSbEb3q7